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nanoparticles in the regulation of AKT and RhoA 
 
ABSTRACT 
Cancer is a complex multifactorial disease and leading causes of death worldwide. Despite the 
development of many anticancer drugs, there is a reduced survival rate due to severe side 
effects. The nontargeted approach of convention drugs is one of the leading players in context 
to toxicity. Hyaluronan is a versatile bio-polymer and ligand of the receptor (CD44) on cancer 
cells. The MCF-7 and HT-29 cancer cell lines treated with hyaluronic acid-paclitaxel (HA-
PTX) showed the distinguishing morphological features of apoptosis. Flow cytometric analysis 
showed that HA-PTX induces apoptosis as a significant mode of cell death. The activation 
level of tumor suppressor protein (p53) increased after PTX treatment in MCF-7, but no 
changes observed in HT-29 might be due to hereditary mutations. The lack of suppression in 
AKT and Rho A protein suggest the use of possible inhibitors in future studies which might 
could play a role in increasing the sensitivity of drug towards mutated cells line and reducing 
the possibilities for cancer cell survival, migration, and metastasis. 
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